Back to search
FDAFDA · Food and drugs·Recall number Z-2791-2016

Supracondylar Nail T2 SCN 09x300 mm T2 Supracondylar Nail System is intended to provide strong and stable internal fixation with minimal soft tissue irritation of the distal femur. (1( Open and closed femoral fractures, (2) Pseudoarthrosis and correction osteotomy, (3) Pathologic fractures, impending pathologic fractures, and tumor resections, (4) Supracondylar fractures, including those with intra-articular extension, (5) Fractures distal to a Total Hip Prosthesis and (6) Non-unions and malunions

Published September 21, 2016 · Recall initiated: June 30, 2016

Summary

FDA records medical device Class II recall Z-2791-2016, published September 21, 2016 and initiated June 30, 2016. Recalling firm: Stryker Howmedica Osteonics Corp.; Status: Terminated; Reported quantity: 1 unit in total; Lot: Catalog number 18220930S and Lot Code K836729. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Stryker discovered that a Tibial Nail and femoral Nail were incorrectly labeled and distributed to the field.

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Stryker Howmedica Osteonics Corp.
Distributor
US distribution to state of: CA.
Lot
Catalog number 18220930S and Lot Code K836729
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Supracondylar Nail T2 SCN 09x300 mm T2 Supracondylar Nail System is intended to provide strong and stable internal fixation with minimal soft tissue irritation of the distal femur. (1( Open and closed femoral fractures, (2) Pseudoarthrosis and correction osteotomy, (3) Pathologic fractures, impending pathologic fractures, and tumor resections, (4) Supracondylar fractures, including those with intra-articular extension, (5) Fractures distal to a Total Hip Prosthesis and (6) Non-unions and malunions recalled?

Yes. FDA published recall Z-2791-2016 on September 21, 2016. Reported hazard: Stryker discovered that a Tibial Nail and femoral Nail were incorrectly labeled and distributed to the field.

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail